Modified alginates for cell encapsulation and cell therapy
US10292936B2 · kind B2 · utility
3Cited by
7References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 5, 2017 |
| Grant date | May 21, 2019 |
| Priority date | — |
| Expiry date | May 5, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5161
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for the encapsulation and transplantation of cells. Also disclosed are high throughput methods for the characterizing the biocompatibility and physiochemical properties of modified alginate polymers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.